Navigation Links
Digital Assent Secures $2 Million Series A Financing to Grow PatientPad Point-of-Care Network
Date:1/24/2011

Ohio, Texas and south Florida. If all goes as planned, the company may be seeking an additional $5 million to $10 million in funding through a Series B round of financing by year's end to grow the product footprint, add new revenue streams, and expand into other health-care disciplines.

About Digital Assent

Founded in 2009, Digital Assent is a fast-growing healthcare technology company based in Atlanta, Ga.  The company's wireless touch-screen PatientPad solution streamlines the patient check-in process and delivers targeted health information to patients while they sit in a provider's waiting or exam room.  By automating patient intake, the PatientPad enables healthcare providers to collect patient information in a standard electronic format, transition from paper to electronic health records, and improve the overall patient experience.  The PatientPad recently won the "2010 Cool Technology of the Year" award presented by TechAmerica and the Technology Association of Georgia.  For more information about Digital Assent and the company's rapidly growing PatientPad point-of-care network, please visit www.digitalassent.com or www.patient-pad.com.


'/>"/>
SOURCE Digital Assent
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ProUroCare Medical Completes Clinical Trial at Second Study Site Using Digital Prostate Imaging Technology
2. Verathon Introduces the GlideScope(R) Cobalt Advanced Video Laryngoscope (AVL); New Digital Technology Facilitates Quick Intubations
3. Escalon(R) Subsidiary Escalon Digital Solutions Announces Release of Web-Based AXIS(TM) Image Management System
4. Now Approved: Fujifilms FDR AcSelerate Direct Digital DR System
5. World Renowned Physician and Thought Leader Dr. Eric J. Topol to Highlight Digital Medicine Revolution at International CES 2010
6. Womens Digital Imaging Using DXA Total Body Fat Analysis to Help Patients in Weight Management and Fitness Programs
7. Frost & Sullivan to Speak at 2010 International Consumer Electronics Digital Health Summit
8. Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago
9. Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard
10. Raytheon BBN Technologies Licenses Stereo Digital Mammography Technology to FUJIFILM Corporation
11. Volcano Receives FDA Clearance to Market the Eagle Eye(R) Platinum Digital IVUS Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... A hernia is condition in which ... the wall of a weak muscle area. Obesity, poor nutrition, ... of the causes of hernias. There are several types of ... inguinal hernia is when part of the abdominal tissue/organ protrudes ... the area of the umbilicus. A hiatal hernia is when ...
(Date:11/26/2014)... NEW YORK and LONDON ... leading distributor of market intelligence, MarketResearch.com is pleased to ... IQ4I Research and Consultancy focusing on the active pharmaceutical ... IQ4I Research visit: http://www.marketresearch.com/land/publisher.asp?vendorid=4023&progid=86891 . ... Global Market – Forecast to 2020 , ...
(Date:11/26/2014)... , Nov. 25, 2014  Medtronic,s roughly ... has been widely discussed in the media for ... creating a stronger leading player in one of ... Information.  The healthcare market research firm said  the ... feature a diverse set of solutions spanning inpatient ...
Breaking Medicine Technology:Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 3Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 4MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3
... May 8, 2012  Par Pharmaceutical Companies, Inc. (NYSE: ... March 31, 2012. For the first quarter ended ... million and a loss from continuing operations of $28.7 million, ... charge related to the Company,s best estimate of loss related ...
... 8, 2012 Stereotaxis, Inc. (NASDAQ: STXS ) ... 31, 2012.  Management Comments ... Stereotaxis, said, "In the first quarter, we continued to capitalize ... Solution and robust utilization, realizing a 20% improvement in revenue ...
Cached Medicine Technology:Par Pharmaceutical Companies Reports First Quarter 2012 Results 2Par Pharmaceutical Companies Reports First Quarter 2012 Results 3Par Pharmaceutical Companies Reports First Quarter 2012 Results 4Par Pharmaceutical Companies Reports First Quarter 2012 Results 5Par Pharmaceutical Companies Reports First Quarter 2012 Results 6Par Pharmaceutical Companies Reports First Quarter 2012 Results 7Par Pharmaceutical Companies Reports First Quarter 2012 Results 8Par Pharmaceutical Companies Reports First Quarter 2012 Results 9Par Pharmaceutical Companies Reports First Quarter 2012 Results 10Stereotaxis Reports Improved First Quarter 2012 Financial Results 2Stereotaxis Reports Improved First Quarter 2012 Financial Results 3Stereotaxis Reports Improved First Quarter 2012 Financial Results 4Stereotaxis Reports Improved First Quarter 2012 Financial Results 5Stereotaxis Reports Improved First Quarter 2012 Financial Results 6Stereotaxis Reports Improved First Quarter 2012 Financial Results 7Stereotaxis Reports Improved First Quarter 2012 Financial Results 8
(Date:11/26/2014)... NC (PRWEB) November 26, 2014 German ... of materials science can cause mesothelioma that looks and ... posted a new article on the research. Click ... the Fraunhofer Institute for Toxicology and Experimental Medicine in ... While all of the rats eventually developed ...
(Date:11/26/2014)... Loffler Companies has been selected as a ... online information and news publication for resellers of imaging ... year Loffler has earned this prestigious award and the ... Awards honor the best and the brightest in the ... were chosen for their innovative marketing and sales programs, ...
(Date:11/26/2014)... Senior Planning Services, providing “expert guidance for elder ... the adult demographic education and access to computer ... rough seas of applying for Medicaid. Part of this ... of Medicaid eligibility and proper planning, while also helping ... this coverage. , Senior Planning Services has made ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Call 866-997-4948 ... requirements or email the details on sales(at)researchmoz(dot)us , ... and drug discovery market 2014" with deep study of ... the result of high blood sugar. The global glucose ... linked to the growing number of diabetics in the ...
(Date:11/26/2014)... November 26, 2014 Louisiana Back ... and specialists in minimally invasive spine surgery, announces ... into the rapidly growing provider network of orthopedic ... addition coincides with the network’s continuing success providing ... for Louisiana residents who are suffering from orthopedic ...
Breaking Medicine News(10 mins):Health News:Multi-walled Nanotubes Linked to Mesothelioma in New Study, According to Surviving Mesothelioma 2Health News:Loffler Companies Recognized as an Elite Dealer for Sixth Consecutive Year 2Health News:Senior Planning Services Teams Up with SeniorNet To Educate Seniors On Medicaid Planning 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:Louisiana Back Institute Welcomes Dr. K. Samer Shamieh into Medical Provider Network 2
... do not achieve statistical significance, - GPC Biotech schedules conference call ... ... ET/13:30 CET, BOULDER, Colo., MARTINSRIED, Germany, MUNICH, Germany and PRINCETON,N.J., ... AG (Frankfurt Stock Exchange: GPC; TecDAX index; Nasdaq:,GPCB) today announced topline ...
... Survival Results Do Not Achieve Statistical Significance, ... SPPI ) licensee, GPC Biotech, today,announced that ... the,treatment of hormone-refractory prostate cancer did not meet ... that the overall survival data for,satraplatin did not ...
... Oct. 30 Barr,Pharmaceuticals, Inc. (NYSE: BRL ... has received tentative approval from the U.S. Food ... Boehringer Ingelheim,Pharmaceuticals, Inc.,s Mirapex(R) (Pramipexole Dihydrochloride) Tablets,0.125mg, 0.25mg, ... it is the,first to file an Abbreviated New ...
... at the Albert Einstein College of Medicine of Yeshiva ... can be successfully treated by targeting the viruses ... 31 issue of PloS One, also raise the possibility ... turn cancerous. , The Einstein researchers used a technique ...
... 79% Growth Over Prior Year Quarter; ... 2008 Guidance, COEUR D,ALENE, Idaho, Oct. 30 ... provider of radiology,solutions to radiology groups across the United ... September 30, 2007. Revenue,grew 79% year-over-year to a record ...
... and OMX Nordic Exchange: EPCT) today announced that Jack ... BioFin Rodman & Renshaw,9th Annual Healthcare Conference on November ... York Palace Hotel in New York. Mr. Talley will ... The presentation will be available live via webcast ...
Cached Medicine News:Health News:Pharmion and GPC Biotech Announce Results of Overall Survival Analysis From the Satraplatin Pivotal Phase 3 Trial 2Health News:Pharmion and GPC Biotech Announce Results of Overall Survival Analysis From the Satraplatin Pivotal Phase 3 Trial 3Health News:Pharmion and GPC Biotech Announce Results of Overall Survival Analysis From the Satraplatin Pivotal Phase 3 Trial 4Health News:GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial 2Health News:GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial 3Health News:Barr Receives Tentative Approval for a Generic Version of Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg and 1.5mg 2Health News:Barr Receives Tentative Approval for a Generic Version of Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg and 1.5mg 3Health News:Barr Receives Tentative Approval for a Generic Version of Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg and 1.5mg 4Health News:Einstein scientists treat cancer as an infectious disease -- with promising results 2Health News:Einstein scientists treat cancer as an infectious disease -- with promising results 3Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 2Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 3Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 4Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 5Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 6Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 7Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 8Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 9Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 10Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 11Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 12Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 13Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 14Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 15Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 16Health News:EpiCept Corporation To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2Health News:EpiCept Corporation To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 3
This 10 L tip was designed for the Pipetman P-2 and P-10. Its MicroPoint design and 2 L reference mark make it ideal for low volume pipetting....
... Gilson disposable pipette tips, TowerPacks ... version. Each Sterilized TowerPack is ... plastic to help protect tips ... by the red sticker, which ...
... racks of 96 tips, Sterilized Diamond- Tips ... Sterilized Diamond Tips are irradiated by gamma-rays ... with a certificate of sterilization, specifying the ... certified free of detectable Rnase, Dnase, DNA, ...
MBP's extra long 200 L pipet tip will reach the bottom of large tubes and vials, preventing your pipettor from contacting the sample container....
Medicine Products: